| Primary |
| Drug Use For Unknown Indication |
51.1% |
| Tourette's Disorder |
8.5% |
| Cerebral Palsy |
4.3% |
| Product Used For Unknown Indication |
4.3% |
| Sedation |
4.3% |
| Abdominal Pain Upper |
3.2% |
| Bladder Disorder |
3.2% |
| Depression |
3.2% |
| Nervous System Disorder |
3.2% |
| Anxiety |
2.1% |
| Hyperaesthesia |
2.1% |
| Hyperphagia |
2.1% |
| Nasopharyngitis |
2.1% |
| Adverse Drug Reaction |
1.1% |
| Anaesthesia |
1.1% |
| Immunisation |
1.1% |
| Psychotic Disorder |
1.1% |
| Skin Infection |
1.1% |
| Tic |
1.1% |
|
| Weight Increased |
21.7% |
| White Blood Cell Count Increased |
17.4% |
| Depression |
8.7% |
| Anxiety |
4.3% |
| Dyskinesia |
4.3% |
| Headache |
4.3% |
| Heart Rate Increased |
4.3% |
| Incontinence |
4.3% |
| Medication Error |
4.3% |
| Pharmaceutical Product Complaint |
4.3% |
| Speech Disorder |
4.3% |
| Suicide Attempt |
4.3% |
| Syncope |
4.3% |
| Tremor |
4.3% |
| Weight Decreased |
4.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
21.7% |
| Sedation |
13.5% |
| Product Used For Unknown Indication |
9.8% |
| Psychotic Disorder |
9.4% |
| Depression |
6.1% |
| Anxiety |
5.3% |
| Tourette's Disorder |
4.9% |
| Hyperphagia |
4.1% |
| Schizophrenia |
4.1% |
| Hyperaesthesia |
2.5% |
| Liver Transplant |
2.5% |
| Restlessness |
2.5% |
| Tic |
2.0% |
| Atrial Fibrillation |
1.6% |
| Atrial Flutter |
1.6% |
| Autism Spectrum Disorder |
1.6% |
| Cerebral Palsy |
1.6% |
| Incontinence |
1.6% |
| Irritability |
1.6% |
| Mental Impairment |
1.6% |
|
| Weight Increased |
13.8% |
| Death |
12.1% |
| Rabbit Syndrome |
8.6% |
| Self Injurious Behaviour |
8.6% |
| Tremor |
8.6% |
| White Blood Cell Count Increased |
6.9% |
| Coma |
5.2% |
| Incontinence |
5.2% |
| Rhabdomyolysis |
5.2% |
| Depression |
3.4% |
| Subileus |
3.4% |
| Ventricular Extrasystoles |
3.4% |
| Ventricular Fibrillation |
3.4% |
| Acute Psychosis |
1.7% |
| Anxiety |
1.7% |
| Convulsion |
1.7% |
| Drug Administration Error |
1.7% |
| Drug Ineffective |
1.7% |
| Drug Interaction |
1.7% |
| Dyskinesia |
1.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
17.7% |
| Drug Use For Unknown Indication |
15.3% |
| Schizophrenia |
8.9% |
| Bipolar Disorder |
8.1% |
| Tourette's Disorder |
7.3% |
| Urinary Tract Infection |
5.6% |
| Dementia Alzheimer's Type |
4.8% |
| Epilepsy |
4.8% |
| Mania |
4.8% |
| Psychotic Disorder |
4.8% |
| Anxiety Disorder |
2.4% |
| Extrapyramidal Disorder |
2.4% |
| Affective Disorder |
1.6% |
| Asthma |
1.6% |
| Bacterial Infection |
1.6% |
| Convulsion |
1.6% |
| Huntington's Disease |
1.6% |
| Multiple Sclerosis |
1.6% |
| Schizoaffective Disorder |
1.6% |
| Schizophrenia, Paranoid Type |
1.6% |
|
| Diabetes Mellitus |
8.9% |
| Rash |
6.7% |
| Suicidal Ideation |
6.7% |
| Vomiting |
6.7% |
| Weight Increased |
6.7% |
| Drug Ineffective |
4.4% |
| Drug Interaction |
4.4% |
| Eye Movement Disorder |
4.4% |
| International Normalised Ratio Increased |
4.4% |
| Overdose |
4.4% |
| Pulmonary Embolism |
4.4% |
| Rash Generalised |
4.4% |
| Renal Failure |
4.4% |
| Speech Disorder |
4.4% |
| Supportive Care |
4.4% |
| Tremor |
4.4% |
| Urinary Incontinence |
4.4% |
| Vaginal Infection |
4.4% |
| Weight Decreased |
4.4% |
| Blood Creatine Phosphokinase Increased |
2.2% |
|
| Interacting |
| Drug Use For Unknown Indication |
50.0% |
| Chronic Obstructive Pulmonary Disease |
16.7% |
| Depression |
16.7% |
| Schizophrenia |
16.7% |
|
| Torsade De Pointes |
100.0% |
|
